Viropro, Inc. Signs a Binding Letter of Agreement For a Multi Million Development Contract With NASDAQ Listed Spectrum Pharmaceuticals, Inc. Viropro is pleased to announce it has signed a binding Letter of Agreement (“LOA”) with Spectrum Pharmaceuticals, Inc. of Irvine, CA, for the development and clinical production of a biosimilar version of Rituximab, a monoclonal […]